Hereditary transthyretin-related amyloidosis is frequent in polyneuropathy and cardiomyopathy of no obvious aetiology-Reference-Cited by-同舟云学术

Hereditary transthyretin-related amyloidosis is frequent in polyneuropathy and cardiomyopathy of no obvious aetiology

Published:2021-01-01 Issue:1 Volume:53 Page:1787-1796
ISSN:0785-3890
Container-title:Annals of Medicine
language:en
Short-container-title:Annals of Medicine

Author:

Skrahina Volha¹,Grittner Ulrike¹²³^ORCID,Beetz Christian¹,Skripuletz Thomas⁴,Juenemann Martin⁵,Krämer Heidrun H.⁵,Hahn Katrin⁶,Rieth Andreas⁷,Schaechinger Volker⁸,Patten Monica⁹,Tanislav Christian¹⁰,Achenbach Stephan¹¹,Assmus Birgit¹²,Knebel Fabian³¹³¹⁴,Gingele Stefan⁴,Skrahin Aliaksandr¹,Hartkamp Jörg¹,Förster Toni M.¹,Roesner Sabine¹,Pereira Catarina¹,Rolfs Arndt¹¹⁵

Affiliation:

1. CENTOGENE GmbH, Rostock, Germany

2. Institute of Biometry and Clinical Epidemiology, Charité–Universitätsmedizin Berlin, Berlin, Germany

3. Berlin Institute of Health, Berlin, Germany

4. Department of Neurology, Hannover Medical School, Hannover, Germany

5. Department of Neurology, University Hospital Giessen and Marburg, Giessen, Germany

6. Department of Neurology, Charité–Universitätsmedizin Berlin, Berlin, Germany

7. Department of Cardiology, Kerckhoff Heart and Lung Center, Bad Nauheim, Germany

8. Department of Cardiology, Klinikum Fulda, Fulda, Germany

9. Department of Cardiology, University Heart and Vascular Center, Hamburg, Germany

10. Department of Neurology, Evangelisches Jung Stilling Krankenhaus GmbH, Siegen, Germany

11. Department of Cardiology, Erlangen University Hospital, Erlangen, Germany

12. Division of Cardiology and Angiology, University Hospital Giessen and Marburg, Giessen, Germany

13. Medizinische Klinik mit Schwerpunkt Kardiologie und Angiologie, Charité–Universitätsmedizin Berlin, Berlin, Germany

14. German Centre for Cardiovascular Research, Berlin, Germany

15. University Medicine, University Rostock, Rostock, Germany

Funder

Alnylam Pharmaceuticals Inc.

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/07853890.2021.1988696

Reference47 articles.

1. Familial amyloid polyneuropathy

2. Online Registry for Mutations in Hereditary Amyloidosis Including Nomenclature Recommendations

3. Expert consensus recommendations to improve diagnosis of ATTR amyloidosis with polyneuropathy

4. Hereditary transthyretin amyloidosis: a model of medical progress for a fatal disease

5. An amyotrophic lateral sclerosis-like syndrome revealing an amyloid polyneuropathy associated with a novel transthyretin mutation

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Switching from inotersen to eplontersen in patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy: analysis from NEURO-TTRansform;Journal of Neurology;2024-08-13

2. Amyloid Neuropathy: From Pathophysiology to Treatment in Light‐Chain Amyloidosis and Hereditary Transthyretin Amyloidosis;Annals of Neurology;2024-06-24

3. Clinical spectrum of Transthyretin amyloidogenic mutations among diverse population origins;Human Genomics;2024-03-25

4. Hereditary transthyretin amyloid neuropathies: advances in pathophysiology, biomarkers, and treatment;The Lancet Neurology;2023-11

5. Hereditary transthyretin amyloidosis in middle-aged and elderly patients with idiopathic polyneuropathy: a nationwide prospective study;Amyloid;2023-10-19